Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation
Phytomedicine Plus · 2023-05 · 3 (2) · 100429
DOI: 10.1016/j.phyplu.2023.100429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine Plus, 2023-05. Verfasst von Soni Ghumnani und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rashtriya Uchchatar Shiksha Abhiyan, Indian Space Research Organisation.
Abstract (Originalsprache)
Background
Bone remodeling is a balanced, dynamic function of two counteractive processes: osteoblasts-mediated bone formation and osteoclasts-dependent bone resorption. An imbalance between these two processes causes bone diseases. Herein, the effects and molecular modus operandi of plumbagin- a bioactive phytometabolite from Plumbago sp. have been investigated on osteoblast and osteoclast differentiation. Material and Methods: Cell viability assay and Alizarin red-S staining assessed the plumbagin effects on pre-osteoblastic MC3T3-E1 cell viability and differentiation. Alkaline phosphatase activity, the osteoblast-specific genes, and protein expression were investigated by colorimetry, quantitative-PCR and immunoblotting, respectively. TRAP assay and osteoclast-specific proteins' expression assessed plumbagin's effect on osteoclastogenesis. During plumbagin-driven osteoclastogenesis, we used paired-end RNA-sequencing data to identify the key up-/down-regulated DEGs, validation by qPCR, and bioinformatics-based pathway analysis.
Results
Plumbagin at a very low dose (0.25 µM) significantly promoted osteoblast differentiation, as evident from alkaline phosphatase, matrix mineralization, and enhanced expression of osteoblast-specific markers, including Runx2 and its target genes. The reduced TRAP activity, osteoclast-specific protein expression, and RNA sequencing suggested RANKL-induced osteoclastogenesis inhibition by plumbagin at 2 µM..
Conclusion
Plumbagin significantly enhances osteoblast differentiation by enhanced matrix mineralization and osteoblast-specific gene expression but suppresses the RANKL-induced osteoclastogenesis by regulating key osteoclast-specific DEGs and protein expression. Plumbagin can thus significantly influence bone biology and affect bone diseases.
Förderung
- Rashtriya Uchchatar Shiksha Abhiyan
- Indian Space Research Organisation
Zitieren
APA
Ghumnani, S., Barvkar, V. T., Mhaske, S. T., Saha, B., & Ashma, R. (2023). Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation. Phytomedicine Plus, 3(2), 100429. https://doi.org/10.1016/j.phyplu.2023.100429
Vancouver
Ghumnani S, Barvkar VT, Mhaske ST, Saha B, Ashma R. Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation. Phytomedicine Plus. 2023;3(2):100429. doi:10.1016/j.phyplu.2023.100429
BibTeX
@article{Ghumnani2023,
author = {Ghumnani, Soni and Barvkar, Vitthal T. and Mhaske, Suhas T. and Saha, Bhaskar and Ashma, Richa},
title = {Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation},
journal = {Phytomedicine Plus},
year = {2023},
volume = {3},
number = {2},
pages = {100429},
doi = {10.1016/j.phyplu.2023.100429}
}
EUVIMED